These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 14528290)

  • 1. Therapeutic approaches to AIDS-related malignancies.
    Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
    Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-related tumors: integrating antiviral and anticancer therapy.
    Tirelli U; Bernardi D; Spina M; Vaccher E
    Crit Rev Oncol Hematol; 2002 Mar; 41(3):299-315. PubMed ID: 11880206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.
    Hartmann P; Rehwald U; Salzberger B; Franzen C; Diehl V
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):401-10. PubMed ID: 15161439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less cancer--or more--with HAART? Or, reflections on a late opus.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-related malignancies: revisited.
    Cáceres W; Cruz-Amy M; Díaz-Meléndez V
    P R Health Sci J; 2010 Mar; 29(1):70-5. PubMed ID: 20222338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies in HIV: the Indian scenario.
    Dhir AA; Sawant SP
    Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.